EcoDrugPlus

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSOKIG00005004150
Gene Symbol: GRIN2BB
1 Cross references
250 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial

Ensembl ID : ENSOKIG00005050832
Gene Symbol: LOC109906680
3 Cross references
221 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial

Ensembl ID : ENSOKIG00005015328
Gene Symbol: LOC109865731
2 Cross references
223 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSOKIG00005048559
Gene Symbol: LOC109890651
3 Cross references
221 Possible Orthologues:

Glutathione S-Transferase P

Ensembl ID : ENSOKIG00005025921
Gene Symbol: LOC109906033
2 Cross references
147 Possible Orthologues:

Glutathione S-Transferase Pi 1

Ensembl ID : ENSOKIG00005022083
Gene Symbol: GSTP1
3 Cross references
155 Possible Orthologues:

Glutathione S-Transferase Pi 1

Ensembl ID : ENSOKIG00005025843
Gene Symbol: GSTP1
3 Cross references
157 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSOKIG00005027874
Gene Symbol: GSK3B
3 Cross references
211 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSOKIG00005012978
Gene Symbol: GSK3B
3 Cross references
211 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSOKIG00005032382
Gene Symbol: GSK3B
3 Cross references
171 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta

Ensembl ID : ENSOKIG00005034313
Gene Symbol: LOC109907543
3 Cross references
181 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSOKIG00005034799
Gene Symbol: LOC109877714
3 Cross references
182 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).